MS
Morgan Stanley
MS has the edge over NRIM overall, supported by stronger fundamentals and stronger modeled upside.
NRIM
Northrim BanCorp, Inc.
NRIM trails on the overall score without a compensating advantage in the available component scores.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
NRIM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
NRIM's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like NRIM.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
NRIM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.4x | $18.20 | -24% |
| Fair | 8.8x | $21.73 | -9.7% |
| Forward | 9.2x | $24.05 | — |
| Current | 9.7x | $24.05 | — |
| Expensive | 11x | $28.11 | +17% |
Historical ranges are pointers, not guarantees.
NRIM has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over NRIM on the outlook, with more favorable profitability expectations.
NRIM Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for NRIM, but weaker profitability.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
NRIM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.63 | +6.3% |
| Q3 2026 | $2.47 | -12% |
| Q2 2026 | $3.04 | +52% |
| Q1 2026 | $2.88 | +53% |
| Q4 2025 | $2.87 | +73% |
| Q3 2025 | $2.80 | +90% |
| Q2 2025 | $2.00 | +39% |
| Q1 2025 | $1.88 | +47% |
| Q4 2024 | $1.66 | +48% |
NRIM earned $2.47 per share over the past year, down 12% from the year before.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over NRIM on profitability, with a higher operating margin.
NRIM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $59.6M | -10% |
| Q2 2026 | $53.9M | +7.2% |
| Q1 2026 | $49.5M | +8.9% |
| Q4 2025 | $51.7M | +18% |
| Q3 2025 | $66.6M | +65% |
| Q2 2025 | $50.2M | +37% |
| Q1 2025 | $45.5M | +33% |
| Q4 2024 | $43.9M | +32% |
NRIM's revenue is growing: $60M last quarter, down 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 31% | -21 points |
| Q2 2026 | 38% | +6.1 points |
| Q1 2026 | 36% | -2.4 points |
| Q4 2025 | 32% | +1.8 points |
| Q3 2025 | 52% | +23 points |
| Q2 2025 | 31% | -0.2 points |
| Q1 2025 | 39% | +8 points |
| Q4 2024 | 30% | +5.2 points |
NRIM's operating margin was 31% last quarter, down 20 points from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
NRIM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$14.4M | -116% |
| Q2 2026 | $39.5M | +$44.2M |
| Q1 2026 | $24.3M | +49% |
| Q4 2025 | $32.3M | -12% |
| Q3 2025 | $89.9M | +$90.3M |
| Q2 2025 | -$4.7M | +$34.2M |
| Q1 2025 | $16.3M | +$22.9M |
| Q4 2024 | $36.5M | -26% |
NRIM has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over NRIM on shareholder dilution, with a more favorable share count trend.
NRIM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +33.2K shares |
| 1 year | +0.3% | +75K shares |
| 3 years | +0.3% | +78K shares |
| 5 years | -9.9% | -2.5M shares |
| Available history | -17% | -4.7M shares |
NRIM has 23M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $1,000 |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $788,000 |
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
NRIM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2019 | -0.4x | Net Cash |
NRIM has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like NRIM.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
NRIM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.9 | Neutral |
| Stochastic | 18.0 | Oversold |
NRIM's weekly RSI is 44 (neutral) and its Stochastic is 18 (oversold).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
NRIM PE vs Financial Services Sector
| Metric | NRIM | Sector median | Relative |
|---|---|---|---|
| PE | 9.7x | 13x | 25% below |
| PE % | 62 | 63 | 1 pt below |
NRIM has the edge over MS on valuation relative to its sector.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over NRIM on trend strength, trading above more of its moving averages.
NRIM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $24.1 | 0.2% below |
| 20 week MA | $25.6 | 6% below |
| 50 week MA | $25.3 | 4.9% below |
| 100 week MA | $23.3 | 3.4% above |
| 200 week MA | $18.2 | 32% above |
NRIM has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 32% above its 200-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over NRIM on returns for 2026, with the stronger performance.
NRIM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.49 | $8.24 | -13% |
| 2021 | $8.24 | $10.7 | +30% |
| 2022 | $10.7 | $13.7 | +27% |
| 2023 | $13.7 | $14.3 | +4.7% |
| 2024 | $14.3 | $19.3 | +35% |
| 2025 | $19.3 | $27.1 | +41% |
| 2026 YTD | $27.1 | $24.1 | -11% |
NRIM has finished higher in five of the last six years. It's down 11% so far in 2026.